MIB-1 immunoreactivity correlates with metastatic dissemination in primary thick cutaneous melanoma

Journal of the American Academy of Dermatology

Volumn 35, Issue 3 PART I, 1996, Pages 416-418

  Böni, Roland ^a  

^a Department of Dermatology ^*  (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY KI 67;

ANTIBODY DETECTION; ANTIGEN RECOGNITION; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MELANOMA; METASTASIS; PREDICTION; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; ANTIGENS, NUCLEAR; AUTOANTIGENS; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; DISEASE-FREE SURVIVAL; EPITOPES; FIXATIVES; FOLLOW-UP STUDIES; FORMALDEHYDE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MELANOMA; MULTIVARIATE ANALYSIS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PARAFFIN EMBEDDING; PROGNOSIS; REGRESSION ANALYSIS; SKIN NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0029775064     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0190-9622(96)90607-6     Document Type: Article

References (3)

1. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1970;172:902-8.
2. Soong SJ. A computerized mathematical model and scoring system for predicting outcome in melanoma patients. In: Balch CM, Houghton AN, Milton GW, et al, editors. Cutaneous melanoma. 2nd ed. Philadelphia: JB Lippincott, 1992:200-12.
3. Tubiana M, Courdi A. Cell proliferation kinetics in human solid tumors: relation to probability of metastatic dissemination and long-term survival. Radiother Oncol 1989;15:1-18.